Clinical Trials
73 trialsSANGUINE
JaxBio Ltd
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
FATIGUE
University of Aberdeen
TEDROMM
Regina Elena Cancer Institute
Step down ward
Siriraj Hospital
Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Midwest Heart & Vascular Specialists
Biomechanical and Metabolic Assessment Pre and Post Vertebroplasty in Multiple Myeloma Patients With Vertebral Collapse
Centro di Riferimento Oncologico - Aviano
CAREMM-2305
Seoul St. Mary's Hospital
Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)
Centro di Riferimento Oncologico - Aviano
CARS
Cedars-Sinai Medical Center
PAMM-HAD1
Assistance Publique - Hôpitaux de Paris
CHIME
The Christie NHS Foundation Trust
THD-MM-Reg
Turkish Hematology Association
Examination of Trends in Multiple Myeloma Trial Patient Experiences
Power Life Sciences Inc.
AATF/Che-1
Regina Elena Cancer Institute
Changing Over Time of Ascorbic Acid After Chemotherapy
Maastricht University Medical Center
The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics
First Affiliated Hospital Xi'an Jiaotong University
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Ultra-low-dose Whole-body CT Using AI-based CT Reconstruction in Patients With Multiple Myeloma
Seoul National University Hospital
ctDNA Methylation Sequencing for Myeloma
Institute of Hematology & Blood Diseases Hospital, China
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT
PETHEMA Foundation
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
Dong-A University Hospital
Investigation of Bone Defects and Microcirculation With Computed Tomography and Magnetic Resonance Imaging
German Cancer Research Center
Serum NGAL IN Patients With Multiple Myeloma
Assiut University
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
University Hospital, Bonn
SPACE2
Weprom
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
Beijing Chao Yang Hospital
A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab
Peking Union Medical College Hospital
MMSPORADGEN
Hospices Civils de Lyon
BPMM
Sheffield Teaching Hospitals NHS Foundation Trust
THERMAL
Malaghan Institute of Medical Research
COSMOS
University College, London
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
Tel-Aviv Sourasky Medical Center
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
HealthTree Foundation
ROADMAP-MM
University of Athens
Cardiovascular Complications of Carfilzomib Treatment
University of Athens
CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19)
Institute of Cancer Research, United Kingdom
Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)
Assistance Publique - Hôpitaux de Paris
DB-FU-IFM2009
University Hospital, Toulouse
ICARE
European Georges Pompidou Hospital
Multiple Myeloma (MM) Quality of Life (QOL) Study
Massachusetts General Hospital
CTFEA Myeloma Study
Tel-Aviv Sourasky Medical Center
MYELODOM
Centre Hospitalier Universitaire de la Guadeloupe
Etiology of Multiple Myeloma: A Case-Control Study
M.D. Anderson Cancer Center
Place of the Hevylite Test in the Evaluation of MRD in Myeloma
University Hospital, Montpellier
EUCADD
Shanghai Changzheng Hospital